compounds serve place idea resilience pill compelling researchers not directly involved mount sinai research ability provide treatment increase stress resiliency cellular level hopefully behavioral level welcomed addition antidepressant armamentarium says gerard sanacora professor psychiatry yale university school medicine director yale depression research program cautions drawing conclusions animal studies early stage clinical trials cites group experience novel antidepressant candidate initially looked promising failed placebo controlled trial moving forward potential resilience pill warranted notes robert sapolsky stanford university professor neuroscience massive number people depression not helped current drugs definitely worth try approach pursued mount sinai investigators novel sapolsky says focusing reductive mechanisms